Senescence and NFκB: A Trojan horse in tumors?

OncoImmunology

Volumn 1, Issue 9, 2012, Pages 1594-1597

  Crescenzi, Elvira ^a   De Palma, Raffaele ^b   Leonardi, Antonio ^c  

^a Istituto di Endocrinologia Ed Oncologia Sperimentale   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Fas; Immune response; NF B; SASP; Senescence

Indexed keywords

B RAF KINASE; CCAAT ENHANCER BINDING PROTEIN BETA; CHEMOKINE RECEPTOR CXCR2; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P53; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

CELL AGING; CELL TRANSFORMATION; CYTOKINE RELEASE; GROWTH DISORDER; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 84886624453     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22525     Document Type: Note

References (28)

1. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/nature02118.
2. Suram A, Kaplunov J, Patel PL, Ruan H, Cerutti A, Boccardi V, et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 2012; 31:2839- 51; PMID:22569128; http://dx.doi.org/10.1038/emboj.2012.132.
3. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, et al. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 1999; 59:3761-7; PMID:10446993.
4. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5:99-118; PMID:20078217; http://dx.doi.org/10.1146/annurev-pathol-121808-102144.
5. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-68; PMID:19053174; http://dx.doi.org/10.1371/journal.pbio.0060301.
6. Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008; 20:150-5; PMID:18353625; http://dx.doi.org/10.1016/j.ceb.2008.01.007.
7. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2002; 109:335-46; PMID:12015983; http://dx.doi.org/10.1016/S0092-8674(02)00734-1.
8. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019- 31; PMID:18555778; http://dx.doi.org/10.1016/j.cell.2008.03.039.
9. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A 2009; 106:17031-6; PMID:19805069; http://dx.doi.org/10.1073/pnas.0905299106.
10. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133:1006-18; PMID:18555777; http://dx.doi.org/10.1016/j.cell.2008.03.038.
11. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657- 67; PMID:18724938; http://dx.doi.org/10.1016/j.cell.2008.06.049.
12. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445:661-5; PMID:17251932; http://dx.doi.org/10.1038/nature05541.
13. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656- 60; PMID:17251933; http://dx.doi.org/10.1038/nature05529.
14. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, et al. ATM-ATRdependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009; 113:3503-11; PMID:19098271; http://dx.doi.org/10.1182/blood-2008-08-173914.
15. Crescenzi E, Pacifico F, Lavorgna A, De Palma R, D'Aiuto E, Palumbo G, et al. NF-κB-dependent cytokine secretion controls Fas expression on chemotherapy- induced premature senescent tumor cells. Oncogene 2011; 30:2707-17; PMID:21278794; http://dx.doi.org/10.1038/onc.2011.1.
16. Ouaaz F, Li M, Beg AA. A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death. J Exp Med 1999; 189:999- 1004; PMID:10075983; http://dx.doi.org/10.1084/jem.189.6.999.
17. Bretz JD, Arscott PL, Myc A, Baker JR Jr. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 1999; 274:25433-8; PMID:10464273; http://dx.doi.org/10.1074/jbc.274.36.25433.
18. Fluhr H, Krenzer S, Stein GM, Stork B, Deperschmidt M, Wallwiener D, et al. Interferongamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. J Cell Sci 2007; 120:4126- 33; PMID:18003704; http://dx.doi.org/10.1242/jcs.009761.
19. Kühnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, et al. NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J Biol Chem 2000; 275:6421- 7; PMID:10692445; http://dx.doi.org/10.1074/jbc.275.9.6421.
20. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 2011; 30:1536-48; PMID:21399611; http://dx.doi.org/10.1038/emboj.2011.69.
21. Hardy K, Mansfield L, Mackay A, Benvenuti S, Ismail S, Arora P, et al. Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell 2005; 16:943-53; PMID:15574883; http://dx.doi.org/10.1091/mbc.E04-05-0392.
22. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E, Chang HY. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 2007; 21:3244-57; PMID:18055696; http://dx.doi.org/10.1101/gad.1588507.
23. Penzo M, Massa PE, Olivotto E, Bianchi F, Borzi RM, Hanidu A, et al. Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. J Cell Physiol 2009; 218:215-27; PMID:18803232; http://dx.doi.org/10.1002/jcp.21596.
24. Rovillain E, Mansfield L, Caetano C, Alvarez- Fernandez M, Caballero OL, Medema RH, et al. Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 2011; 30:2356- 66; PMID:21242976; http://dx.doi.org/10.1038/onc.2010.611.
25. Wang J, Jacob NK, Ladner KJ, Beg A, Perko JD, Tanner SM, et al. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep 2009; 10:1272-8; PMID:19779484; http://dx.doi.org/10.1038/embor.2009.197.
26. Gapuzan ME, Schmah O, Pollock AD, Hoffmann A, Gilmore TD. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Oncogene 2005; 24:6574-83; PMID:16027734.
27. Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, et al. Control of the senescenceassociated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125-36; PMID:21979375; http://dx.doi.org/10.1101/gad.17276711.
28. Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-a feedforward signaling. Cell 2011; 145:92-103; PMID:21458669; http://dx.doi.org/10.1016/j.cell.2011.02.023.